1206
www.klinickafarmakologie.cz340804301076513320121425327329234035839843647950254457164568672477179183988990895196610061045
/26228043010757
KlinFarmakol2698804301077091109157210247273348388426474493
Farm2021;321180430107337096171226269310350359
35(4):359080430107357799140162176
118–1233786804301073570109156194232276
/40818043010768
KLINICKÁ41698043010771114135194215269315373
FARMAKOLOGIE4562804301073484131203258304365407467526547591
A51738043010745
FARMACIE5239804301073483130203258309329373
12356558026012657110167
ORIGINÁLNÍ4694207012673138172244278352422476549582
PRÁCE5297207012661125197257315
Nové247736501063980117149
trendy26413650106316699140180215
v2871365010637
přístupu29233650106336886119151193227268
k3206365010634
léčbě32553650106306297133165
diabetu34353650106385696131164197238
2.368836501063348
typu375036501063170105146
–3911365010646
postřehy397236501063374107140176208249286
a4273365010639
benefity432736501063466108140171188220260
v4601365010637
ambulantní465336501063993129170201243284317358376
praxi504336501063469111149167
diabetologa52243650106395696132164197236268307347388
6.3435610853651
Yandrapalli4095630833362100138159192231264279294308
S,7325630833043
Malik790563083528499114144
A,9495630833852
Horblitt10165630834280101140156171193217
A,12485630833852
et13155630833254
al.1384563083294457
Cardiovascular1456563083377091129144181213246272304341356388409
Safety18805630833063811163436630832255
and4146630833674113
Benefits5426630833975113148165182205232
of7906630834160
Noninsulin8666630834887125140178205242257272310
Antihyperglycemic11916630834584105120158189229264286324339371402436494509541
Drugs17476630835072110149175
for1937663083236082
the343763083225994
Treatment452763083304781113134192227265286
of7537630833554
Type822763083305897133
297076308331
Diabetes1017763083425889128164186219246
Mellitus:12787630835287102117132154192218230
Part1523763083336485110
2.16487630833244
Cardiol1707763083377091129144182197
Rev19197630833368100
2020;28(5):219–235.3438630833468101135148183217236269288300335366396434465500533545
7.3439610853645
Sachinidis402963083316497135150187203241257283
A,7009630834054
Nikolic769963083435989126142157189
D,9739630834455
Stoian1043963083315289105137175
AP,1233963083407580
et13289630833355
al.1399963083304558
Cardiovascular1473963083387192130145183215248275307345360392414
outcomes190296308336749634310630833169128163190
trials549106308327486497112139
with7031063083567295133
incretin-based8521063083205891112147169185223246286320346382422
medications:128910630836399139154186220242257295334361374
a1678106308337
critical1731106308332536992107140173188
review1935106308326603431163083324782133
of49211630833857
data5641163083397294126
available7061163083326497112127159199215249
on97111630833876
GLP-1106311630834476112133164
receptor12431163083215588122161183220241
agonists150011630833372110148163189213240
and175611630833270109
DPP4188111630834682117343126308334
inhibitors.3921263083135189104143159181218240267281
Metabolism68812630835287110142182220236251277335
2020;111:154343.10381263083326699133146176204232240270300335368403436448
Epub150212630833069107146
202016641263083326699133
Aug181212630833976115
16.19421263083336477
8.34313610853653
Pinto4121363083405594116154
LC,5821363083377689
Rados68713630834175115154181
DV,8841363083518897
Remonti99613630834277136175215237253
LR,12641363083377489
et136813630834063
al.14471363083375366
Patient-centered15291363083417496112147186208228263297336358392414449489
Management34314630835689129162202238298334374396
of75514630834464
Type83514630833867108145
2996146308341
Diabetes105314630835168101141178201236264
Mellitus133314630836197114129145168208235
Based158414630834276103139180
on178014630834483
Specific187914630833979116343156308332496885119
Clinical4791563083516884124140174209226
Scenarios:72115630834478114154188211228268296310
Systematic104815630834375104128164225259282299332
Review,139715630834784118135172225237
Meta-analysis16501563083671041281621862212612953123453431663083274269
and42816630833878118
Trial5621663083395773106122
Sequential70016630833975116155191230252268302318
Analysis.103416630834786120136169197212239254
J1304166308330
Clin13501663083466278117
Endocrinol148316630833978118157191213230269308325
Metab182416630836197121154195
2020;105(11):dgaa534.34317630833468101135148178210244261293321335347386425457489524557592605
9.34318610853649
Fillit40718630833348637893115
HM,53818630834499112
Rockwood66618630833574106136190227266306
K,98718630833550
Young105218630833569107145185
JB.12521863083246073
Brocklehurst‘s13411863083355794127157173208246284305332355370395
Textbook17521863083326395119158197236266
of34319630833756
Geriatric4141963083417697113144166187202234
Medicine66319630835286125140172187224259
and93719630832967105
Gerontology.10581963083417697133172193229245283322354363
Seventh14371963083296496130168189227
ed.16791963083317083
Philadelphia,177719630833370851001311702052203432063083397792124137
Elsevier4962063083324773108140156191212
Health72320630834580111127149187
Sciences,9262063083326580114152185218245258
2016:1119.119920630833569100132144174202229259270
10.3432161085366984
American44121630833896130151166198230268
Diabetes7242163083425789128163185218244
Association.9832163083386692130162177208230245282320333
9.133121630833142
Pharmacologic138821630833269101122180212243280295333372387418
Approaches18212163083387711613817434322630833264102137164
to52222630832562
Glycemic5992263083466294126159217232264
Treatment:8792263083355286118140198233271293306
Standards12012263083355689127166198219257284
of150022630834059
Medical157522630835792132147179212227
Care18172263083437697131
in196422630831755
Diabetes-2021.3432363083456193132168190224250271302336369401410
Diabetes7692363083456092132167189223250
Care10342363083407394128
2021;44(Suppl.117823630833468101132140175212232263301340379395408
1):S111–S124.1602236308334486094124152180213243274304336348
11.3432461085366678
Bhatt43624630834079111133157
AS,6082463083468093
Luo71624630833673111
N,84324630834962
Solomon9202463083377692130188226265
N,120024630835062
et127824630833861
al.13542463083375265
TECOS143424630833772112157190
Study16392463083375997136168
Group.182224630834870107145184197
International3432563083155374108129168200222237275314346361
variation7202563083356889105137159174212250
in98625630831856
characteristics105825630833573105126159191216249271286312335351383410
and148425630833573112
clinical16122563083355065103118150183198
outcomes18262563083417910213216934326630835792119
of47826630833958
patients5512663083417496111146184205233
with7992663083536891129
type9432663083245797133
21091266308336
diabetes11432663083405587126162184218244
and140326630833371110
heart152926630833974106127152
failure:1696266308320546984122143177189
Insights19012663083165481963432763083387698125
from4842763083184077136
TECOS.63527630833267107152185198
Am84927630834199
Heart96327630834479111132157
J1135276308324
2019;218:57–65.117427630833569101131144178210241253289322354392425437
12.3432861085366985
Singh4442863083385391131170
AK,6292863083478398
Singh7432863083385392131170
R.92928630834156
SAVOR-TIMI100128630833879113161198221251268324340
to135628630832865
SUSTAIN-6:143728630833882115150187203249272310323
a1775286308338
critical1829286308331536992108140174190
comparison34329630833168126166199220235261300338
of69629630833757
cardiovascular7682963083316485123138176208241268300338353385406
outcome11902963083377597128165223258
trials1464296308321425890105131
of161129630833756
antidiabetic16822963083327091107145161192232267290305337
drugs.3433063083385998137163176
Expert53530630833265104140161186
Rev73630630833570103
Clin8543063083405570108
Pharmacol97730630833573105126185217249286302
2017;10(4):429–442.129430630833569100130140170201221254271283317350384422458495528540
13.3433161085366782
Mohammedi43931630835289127159216273308347362
K,81631630833246
Woodward87731630835490129168218251271309
M,120131630835164
Hirakawa12803163083425677110139172222255
Y,155031630833240
et160531630833153
al.16733163083294457
ADVANCE174531630833883118156201241273
Collaborative3433263083407793108140179218239272294309342376
Group.73432630834163100138177190
Presentations9393263083335387114149187208241263278316354381
of133532630833554
major140432630835588103141162
peripheral15823263083367193108147186220242275290
arterial18873263083305175109343336308321366884
disease4423363083365178113144171206
and66333630833068107
risk786336308319346090
of89233630833554
major96233630835588103141163
outcomes11403363083357496127164222257284
in143933630831351
patients15053363083377092107142180202229
with17503363083486486125
type18903363083205493129
2343346308334
diabetes:3923463083375284124159181215242254
results6623463083195380117133155183
from8603463083173976134
the10103463083205893
ADVANCE-ON111934630833985121159204245278299349395
study.15293463083254886125157167
Cardiovasc17113463083397293131146184216249276308
Diabetol3433563083456193132168190227243
2016;15(1):129.60135630833468100131144174204221253267279309339373384
14.3433661085366984
Anděl44236630834281120154170
M,62736630835669
Němcová71236630834580138170207239272
V,99936630833746
Pavlíková106036630833668100115130162199231264
N,134036630834558
et141436630833557
al.14863663083334961
Faktory15633663083336393117154176210
vedoucí178836630833367107145183215230
k343376308330
poškození38837630833877103133170198232270285
a688376308330
destrukci7333763083387299122143182212243258
B-buněk10063763083335595133171206236
Langerhansových125737630832962100139174195233265303329367399433464502
ostrůvků17743763083356285106144176207245
pankreatu.34338630833972110140162196228250288301
Vnitř6593863083367388111132
Lék8063863083326696
2014;60(9):684–690.91738630833569100132143179215234267285297332368404441478512548561
15.3433961085377085
Charytan44439630834684118139174200234273
DM,732396308352108122
Solomon8703963083397894134193232272
SD,11583963083388496
Ivanovich12703963083205387126165198214247286
P,157239630834146
et163439630834063
al.17133963083385467
Metformin17963963083619712014118020234340630835773111
use46940630834269104
and58840630833775115
cardiovascular7184063083366991129144182214247274306344359392413
events114640630833972106144166194
in135540630832058
patients14284063083447799114149187209237
with16804063083567294132
type182840630832760101136
21980406308339
diabetes3434163083385385124160182216243
and60141630833472111
chronic7274163083337192129167183214
kidney9574163083314786124159191
disease.11634163083405581116148174209222
Diabetes14004163083476294133169191225252
Obes166741630834989124151
Metab183341630835691114146186
2019;21(5):1199–1208.34342630833468100130143178209224258276288318346376411449480510544579592
16.3434361085367086
Fayfman4444363083386899121181214252
M,71243630836074
Galindo8014363083508398114152192230
RJ,10474363083416880
Rubin114343630834179119135173
DJ,13324363083507385
et143343630834062
al.15114363083375366
A1592436308347
Randomized165543630833568107147185244260289324364
Controlled34344630834077115137158196211227261301
Trial659446308331496496112
on78644630833674
the8754463083215994
Safety9844463083316483117140173
and117344630833068107
Efficacy1295446308332496785117150182216
of152644630833655
Exenatide15964463083316498136168190205244279
Therapy1890446308332711063434563083215596128
for4874563083246385
the58845630832867104
Inpatient70845630832059100134156172208247270
Management99445630836195134167207243303339379401
of141145630834364
General149145630835086126162184218234
Medicine174145630836197138154187203242278
and34346630833270110
Surgery4684663083387597135170192226
Patients7094663083417395110145184205233
With95846630836279101140
Type111346630833866106142
21271466308339
Diabetes.13254663083516799139174197231258272
Diabetes16124663083516699138174196230257
Care18854663083457899134
2019;42(3):450–456.34347630833468100130143178210228261278290325358392430466499534547
17.3434861085366775
Mo43348630835289
D,53748630834353
Liu6054863083294481
S,70148630833042
Ma75848630835284
H,85748630834153
et92548630833153
al.9934863083294457
Effects10654863083304867101133157184
of126448630833453
acarbose13324863083296193114153192218252
and159948630832967105
metformin171948630835589111132169190248262300
on34349630833776
the4344963083195792
inflammatory541496308313506885117175232265286323345379
state9354963083244779101135
in108549630831250
newly115049630833570121137169
diagnosed13344963083365183122160198224259299
type16484963083195393128
21792496308331
diabetes183949630833550821211573435063083225582
patients:4415063083366991106141179200228240
a697506308329
one-year74150630833876111134166200232253
randomized10105063083185189128166224240269303342
clinical1368506308328445997112144176192
study.15755063083244785124156166
Drug175650630834365103142
Des191450630834378105
Devel34351630834581113147163
Ther52151630833372107128
2019;13:2769–2776.66551630833468100130143173203214249282314348385417450484516530
18.3435261085366985
Frias4435263083355470102128
JP,5875263083266266
Zimmer66852630834055113171206227
Z,91152630833952
Lam97952630833366124
RLH,111952630833769114127
et126152630833658
al.13355263083334961
Double-blind,141252630834786124163179214237277293308346385397
randomized1825526308322559313217034353630835772102136175
clinical5335363083334964102117149181197
trial745536308323456092108
assessing8685363083346087122149175190228267
the11505363083236297
efficacy1262536308336547290122155187220
and149853630833371110
safety16235363083286180115137171
of180953630833958
early18835363083356788104136
initiation343546308315536890105137159174212251
of60954630834262
sitagliptin6865463083314668101140155170209231247285
during98654630834380102117155194
metformin119554630836398120141179200259274312
uptitration152254630834281103119141163196217233271309
in184654630832058
the191954630832765100
treatment3435563083214376108129187221259280
of63855630833554
patients7075563083366990105139177198226
with9485563083476385123
type10865563083195291127
21228556308331
diabetes:12745563083365182121156178211238250
The153955630833069103
CompoSIT-M165855630833773131170208240254288306361
study.2138563083264987126158168
Diabetes2322563083456092132167189223250
Obes25875630834787123150
Metab27525630835489112144184
2019;21(5):1128–1135.29515630833468100130143178209225258276288318346376409446477505535568580
19.2138661085366982
Müller-Wieland22366630835491107122157178198255271306322354392431
D,26826630834455
Kellerer275366308333688398133154188210
M,29786630835367
Cypryk30606630833966106128162193
K,32686630833448
et33326630833355
al.3402663083314659
Efficacy347666308332506785117150182216
and37076630833169108
safety2138763083265978113135169
of23227630834059
dapagliflozin23977630834173112145184199214232249287315331369
or27817630834062
dapagliflozin28587630834173112145184200215232249287315331369
plus3242763083425895121
saxagliptin3379763083296293126165180195235257272310
versus37047630833569902138863083276592
glimepiride2246863083456176135172212228250266307343
as26058630833765
add-on26868630833878118141182222
to29248630832765
metformin300586308364101124146184207267283322
in33438630832059
patients34188630834579102118153193215244
with3678863083577396136
type2138963083215494128
2228196308331
diabetes.2327963083355081120154176209235249
Diabetes2590963083435889127162184217243
Obes28489630834483118144
Metab30079630835185107139177
2018;20(11):2598–2607.3199963083316596126138172206225256283297308342377408442479510542577609615
20.21381061085367287
Matthews224010630835689111135173208259286
DR,25421063083478397
Paldanius26541063083376984123155193208246272
PM,294110630833791104
Proot30611063083365794133155
P,323110630833742
et328810630833558
al.33611063083334962
Baseline34381063083377097132147162200235
characteristics36881063083337110321381163083215486110144165181207230245277305
in245811630831351
the25251163083205893
VERIFY263311630833569104120153190
study:28381163083254886125157171
a3024116308330
randomized30701163083205391130169227242271305345
trial3430116308320425789105
assessing35501163083315784119146172187225264
the21381263083226096
durability224912630834482103136176192207222245279
of254412630834262
glycaemic26211263083445991123156192250265298
control293412630833774113135156194210
with31601263083567294133
early33081263083407293109141
vildagliptin-34651263083375368108140180195210250272288326349
-metformin213813630832180115137158196217276291329
combination248213630833168126165181219251273288326364
in286213630831452
newly292913630833772123139171
diagnosed31151363083385385124162200227262301
Type34321363083326099135
23582136308334
diabetes.363113630833853851241602138146308322558296
Diabet22491463083456193132168190
Med245414630835590129
2019;36(4):505–513.259914630833468100130143178212231264282293329363397433467498528541
21.21381561085367082
Jia22351563083223769
S,232015630833043
Wang237815630835586124163
Z,255715630833548
Ruobing262115630833371109148164202241
Han287715630834274112
1,300515630833241
et306115630833254
al.31301563083304558
Incretin32031563083135183104138161176214
mimetics343215630835570128163185201233260
and370815630832967106
sodium-glucose213816630832664104119157214237277293330362399426461
co-transporter26141663083367396118140173211237276315337361395416
23046166308338
inhibitors30991663083195795110149165187224246273
as338716630833763
monotherapy3465166308362100139177199237272293326213817630833970
or222317630833657
add-on229517630833069108131170209
to251917630832057
metformin259117630835591113134172193252267305
for29111763083165476
treatment30021763083204175107129187222260281
of329917630833554
type33691763083195393129
23513176308332
diabetes:35601763083375284123159181215241254
a2138186308332
systematic21861863083265987110144203236258273306
review25071863083276194110145197
and271918630833876116
network285018630834479102155194216247
meta-analysis.311218630836399122155178210249282297330357372399412
Acta354018630834779103136
Diabetol3692186308351679921381963083397496133149
2021;58(1):5–18.230319630833468101132141176210229260275287322358389420434
22.21382061085377490
Negro224520630835086127149187
R,244820630834156
Greco251920630835072107141179
EL,27142063083387085
Greco281520630834972107140178
G.300920630835064
Alogliptin308920630834763102143159174214237253291
and339620630833877117
Gliclazide35292063083506682115130163194210250286
Similarly213821630833348107123139172194210243
Increase23972163083205992114149181209245
Circulating26582163083456183115154170203225241280320
Endothelial299421630833877117156179218254270285318334
Progenitor334421630834162101141177216232255293315
Cells36752163083468097112139
in213822630831553
Type220722630833866107143
22366226308339
Diabetes24212263083516799139175198232260
Patients.26962263083417496111147185207236249
Exp296122630833871112
Clin30882263083466177115
Endocrinol321922630833876116155188210226264303319
Diabetes35542263083516799139175198232260
2019;127(4):215–219.213823630833468100130143173203236252285303315350381411448479511541552
23.21382461085367287
Gutierrez224124630834280102117152173195229258
JA,25142463083226276
Scirica2605246308331637899114146179
BM,279924630833388101
Bonaca291624630833371109142174206
MP,31382463083528792
et324524630833254
al.33142463083304558
Prevalence33872463083335387120152168202240273306
and370824630833068107
Outcomes213825630834785108138175233268295
of244825630833554
Polyvascular25172563083337086117152185211244281296329350
(Coronary,28822563083165592114151189221242276286
Peripheral,31832563083336687103142180215236269284297
or349525630833556
Cerebrovascular)3567256308337719212616518622421382663083326491123161176208229248
Disease24012663083435884119151178213
in262926630831250
atients26942663083305267101139161189
With28982663083557194132
Diabetes30452663083435890130165187221248
Mellitus330826630835287103118133155193219
(From35432663083164868105163
the37222663083195792
SAVOR-TIMI213827630833273107154190212242258313329
53248227630833467
Trial).2565276308332506597113132143
Am272327630834199
J2837276308325
Cardiol28772763083407394132147185201
2019;123(1):145–152.309327630833569100131143174203238256288302314344375408444475505538551
24.21382861085367186
Mosenzon224028630835291118153191220257296
O,255128630834556
Leibowitz26222863083296378118156207223245276
G,291428630834154
Bhatt298428630833371103125149
DL314928630834375
et323928630833254
al.33092863083294457
Effect33822863083304968102135159
of355628630833555
Saxagliptin362628630833063951271662138296308315306991106144
on229829630833776
Renal238929630833671109142157
Outcomes256129630834886109140177235270297
in287329630831553
the29422963083226095
SAVOR-TIMI305329630833374107154190212242259314329
53339829630833467
Trial.3481296308333506698113126
Diabetes3622296308346629413316921383063083225582
Care22363063083397293128
2017;40(1):69–76.237930630833468100129139174210229261275287323357394426458471
25.21383161085367287
Zannad224131630834275113151183222
F,247931630833642
Cannon253631630834477115153191229
CP,27813163083437983
Cushman288031630834380106144202234272
WC,3168316308361101114
et329731630833860
al.33733163083355163
EXAMINE345231630833676119175190235268
Investigators.37363163083185621383263083326692115131169201223260281308322
Heart247532630834176108129154
failure2644326308316496479116137171
and283032630833068106
mortality295232630835493114139171186201224257
outcomes32243263083357395126163221256282
in352232630831249
patients35873263083366990105140178199227
with21383363083506688125
type22783363083205392128
22421336308331
diabetes24673363083365082121156178211238
taking2720336308319518197135173
alogliptin29083363083304582121137151190212227264
versus31873363083296384111148174
placebo33763363083365183115148187225
in361733630831249
EXAMINE:368133630833070112213834630835470115148161
a2315346308333
multicentre,236434630835795110132148180213251273294328340
randomised,27203463083225593132170229244270305344357
double-blind309234630834078117156172206230270285300338377
trial3485346308323446092107
Lancet.360834630833366104137170193206
2015;385(9982):2067–2076.213835630833468100130141176210244262294330365398416428463497533566598630664697729742
26.21383661085367187
Marx224136630835385107140
N,239636630834356
Rosenstock24673663083337298133171198221258291321
J,280336630832234
Kahn285336630833366104142
SE,30113663083306276
et310236630833254
al.31723663083294558
Design324536630834379106120159197
and345836630833068107
baseline35803663083377096131147162200235
characteristics213837630833169101122155187211245266281307330346377405
of255837630833554
the26273763083205893
CARdiovascular273537630833780115154170207239272298331368383416437
Outcome318737630834483105136172230265
Trial3468376308330476294110
of359337630833554
LINAgliptin3662376308329448913021383863083385368107130145183
Versus23363863083407294121158184
Glimepiride25363863083476378136171210226247262301336
in288738630831957
Type295938630833764104140
23114386308338
Diabetes31673863083506597136172194228255
(CAROLINA®).343738630832262104140188220236281322347366377
Diab21383963083456193132
Vasc22853963083366794126
Dis24263963083466187
Res25293963083357097
2015;12(3):164–174.264139630833468100130141171201218252269281311342378416447476506519
27.21384061085356977
Rosenstock22304063083326995129166191213249281310
J,255440630832133
Perkovic26014063083326585115151182197228
V,284340630833241
Johansen28984063083215896127164189223260
OE.31734063083437688
CARMELINA327640630833677112166198229243287327
Investigators.3618406308312487911213816017521384163083387092129151178191
Effect23454163083355473108140164
of252541630834059
Linagliptin26004163083344987119158174189228250265303
vs291841630833562
Placebo29954163083385385117151190229
on323941630834079
Major333341630835890105143165
Cardiovascular3513416308343769713515018822025328021384263083316984117138
Events22914263083326498136158186
in249242630831452
Adults255942630834179117132154182
With27564263083577396134
Type290542630833260100136
23056426308334
Diabetes31054263083456092131167189223250
and337042630833170109
High34944263083445997135
Cardiovascular36454263083397293131146213843630833769102129161199214246267
and242143630833472111
Renal254743630833873111143159
Risk:27214363083375379109124
The286043630833574109
CARMELINA298443630834285121176210241257302343
Randomized334243630833871109148186244259288322362
Clinical3719436308342587321384463083385385117133
Trial.2286446308333506697113126
JAMA242744630832464120162
2019;321(1):69–79.260444630833468100130143178211242257289303315351384422454487498
28.21384561085377592
Deacon224745630835491124158197237
CF.25004563083498390
Dipeptidyl260745630835470111149190213229270303321
peptidase294445630834784125149165206240268304
43265456308342
inhibitors332445630832262102118159175199238261289
in363045630832262
the370845630833070107
treatment21384663083224378110132191226264286
of244046630834262
type251746630832761102137
22670466308339
diabetes27254663083435991131166189223250
mellitus.299146630836298114129144167205232245
Nat325246630835083105
Rev337246630834176109
Endocrinol349646630833876116154187209225263301317
2020;16(11):642–653.213847630833468101135148178209228260288302314349386419453490524557569
29.21384861085367285
Chun-Xing223948630834078116154176213228266305
Li,25594863083324759
Shuo263448630833270108146
Liang,27954863083324779117156169
Lingyan29794863083324785124156189227
Gao,322148630834477115127
Hua336348630834582115
Liu.3493486308331478497
Cardiovascular3606486308340739413214718521384963083326591123161176209230
outcomes238349630833977100130167226261288
associated26864963083336086125157172204226260300
with30014963083526890128
SGLT-2314549630833478110139158189
inhibitors33494963083165492107146162184221243270
versus36344963083346889116154180
other21385063083375997132153
glucose-lowering23075063083365188120157184219242258296348382403419457496
drugs28185063083365795134160
in299450630831250
patients30595063083366991106141179201228
with33035063083486386124
type34425063083205393129
23586506308332
diabetes:363350630833651831221582138516308322558295
A2248516308342
real-world23055163083215587102125176214236252290
systematic26115163083276087110143201234256271303
review29295163083225688104139190
and313451630833371110
meta-analysis.325951630835994116149171204242274289321348363389403
PLoS367751630833667105137
One.213852630834786121133
2021;16(2):e0244689.228652630833468101133141171202221255273285319355388420457493528563574
eCollection287552630833475112128143178211235250288327
2021.321752630833468101132142
30.21385361085367287
Leite22415363083306479101135
KM,239253630833289102
Long251053630832967105144
AM,266953630833995108
Ostroff27935363083457295116153173192
ML,30005363083538599
Borges31145363083337293131166193
L,332253630833043
Braden33815363083335487127161199
G.359653630834155
A3667536308339
Review37215363083357021385463083324984137
of229154630834364
the237154630832766102
Renoprotective248954630834278117157197220258281316349374390424459
Effects29645463083395978113147172201
of318154630834363
Novel326054630835191124159175
Antidiabetic345154630834787109125165181214254291314330363
Agents.213855630834179114152174201215
J2368556308325
Pharm240855630833572105126184
Pract26085563083355588121145
2021;34(1):141–148.276855630833468101133141176211231262277289319350380413444475511524
31.3934561085366880
Fitchett402956308330446697134169191214
D,42585630834353
Inzucchi4326563083135079117148179216231
SE,4572563083306174
Cannon46615630833770107144182220
CP,4896563083377276
et49875630833153
al.5055563083294457
Empagliflozin51275630833087125158196211226243260298325341378
Reduced5520563083336739346630833876108141181
Mortality41306630835492114138171186201224258
and44036630833068108
Hospitalization45266630834381108147162185218233248277310332347385424
for4965663083175577
Heart50576630834378110131156
Failure522866308331607691128149184
Across5427663083407192130156183
the3934763083226095
Spectrum40447630833473108141165186225283
of43427630833858
Cardiovascular4415763083417495133148186218251278310348363395416
Risk4847763083365278108
in49707630831654
the5039763083236196
EMPA-REG51517630833389124162183220254298
OUTCOME5464763083499312739348630834085140174
Trial.412386308333506597113126
Circulation4264863083405576107145160193214230268306
2019;139(11):1384–1395.45858630833569100131143174204237256288315330342371401436472509540570603638650
32.3934961085367186
Mahaffey40369630835689127159179198232264
KW,43159630833697106
Neal44379630834681113128
B,45809630833750
Perkovic4645963083377091122159191207239
V,48999630833746
et49619630833557
al.5034963083334861
CANVAS51109630834284130166205239
Program5364963083375795134155188246
Collaborative39341063083407894109141181220242275297313346380
Group.433010630834971109147186199
Canagliflozin454510630834578117149189204219237254293321337375
for49361063083236183
Primary50351063083406177135168189224
and527410630833776115
Secondary54051063083387310614318239341163083387092126
Prevention40751163083385993125160198219234272311
of440111630834160
Cardiovascular44761163083437697136151189221254280312350366398419
Events:491011630833668102140162189202
Results512711630833974101138153176203
From53461163083355592150
the55121163083256398
CANVAS393412630834083128165203237
Program41861263083355593132153186244
(Canagliflozin44451263083185790128161200215230248265303331346384
Cardiovascular48451263083397293131146184216249275308345361393414
Assessment52741263083406895130157183241276314336
Study).39341363083325492131163181192
Circulation41411363083405576107145160193214230268306
2018;137(4):323–334.446213630833569100132144174204236252285303314350382417453486519554566
33.39341461085367085
Wiviott403414630835470102118155176200
SD,42491463083307485
Raz43491463083326493
I,445714630831325
Bonaca449714630833270108140171204
MP471614630835186
et481714630833253
al.48851463083294457
The495714630833068103
design50751463083356995110148186
and527514630832967105
rationale5395146308318517287124162194393415630831549
for39981563083165475
the40881563083195792
Dapagliflozin419515630834375114146185200215233249287315331368
Effect45781563083304968102135158
on475215630833472
Cardiovascular48401563083377090128143181213245272304341356388409
Events52641563083306296134155183
(DECLARE)-TIMI54621563083166194134393416630833175110144164187217233288303
58425316630833468
Trial.4336166308333506698113126
Am447716630834199
Heart459216630834479111132156
J4764166308324
2018;200:83–89.480316630833468100131144178213249262297331367403437448
34.39341761085367388
Bae403817630834174109
JH,41621763083307487
Eun-Gee426517630833874112135181217252
Park,45331763083407293124139
Kim468717630834057114
S,481717630833750
Kim488217630834157115
SM,501217630833892106
Hahn513317630835082120158
S,530717630833750
Kim537217630834057115
NH.550217630835095108
Comparative393418630834077135174207228261283298331365
Renal431518630833469108140155
Effects44861863083325170104137161188
of469018630833756
Dipeptidyl476118630834561100135174197212251283299
Peptidase-4507518630833568107129145184216242277301337
Inhibitors5427186308315539110614516039341963083225980107
and405719630833674113
Sodium-Glucose418519630833675114129167225247294310347379416443478
Cotransporter467819630834481103125158196222261300321346380401
25094196308338
Inhibitors51481963083185694110149164187224245272
on543619630834179
Individual55311963083195739342063083385385101139177209224
Outcomes417320630834483105135172230265291
in448020630831249
Patients45452063083326485100135173194222
with47822063083486385123
Type49202063083305898133
25068206308332
Diabetes:51152063083425890129164186219246258
A5389206308338
Systematic54422063083326288111145393421630835789110125157
Review41062163083336799115149200
and432121630832967105
Network44412163083427799152189210240
Meta-Analysis.469621630835287109141163204242274289320347362388401
Endocrinol511221630833067106144176197212250288303
Metab543021630835287109141180
(Seoul)39342263083195085124162177197
2021;36(2):388–400.414622630833468101133141176210229263281293328363398435472508544557
35.39342361085367186
Linong40352363083304583121160199
Ji,42492363083223750
Xiaolin43142363083365183121137152190
Dong,452023630834381120159172
Yiming470723630833349107122160199
Li492123630833045
et498223630833154
al.50512363083304558
Efficacy5124236308331496784117149182215
and535423630833068107
safety54772363083245776110393424630832255
of400524630833655
once-weekly407624630833675107140164215250285315332364
semaglutide445524630832560118151190205243265280319354
versus48242463083316687114151178
once-daily501724630833675107141164204236252267298
sitagliptin5331246308325406295134150164204226241279
as393425630833258
add-on400825630833372111134173212
to423525630832460
metformin431125630835994116137175197255270308
in463425630831755
patients47042563083417495111145183205233
with49522563083526890129
type50962563083235797133
25244256308336
diabetes52952563083405587126162184218245
in555525630831755
SUSTAIN393426630833275106140176191235
China:41842663083377489126158169
A4368266308338
30-week,44212663083346791142175210240254
double-blind,469026630833572110148164198220260275290327365377
phase508226630833674105131166
3a,52632663083316275
randomized53532663083185087126163220235393427630832862102
trial.4051276308322435991106119
Diabetes41852763083466193132168190224251
Obes445127630834787123149
Metab461627630835489112144184
2021;23(2):404–414.481527630833468101132141176210229262280292327363399436473503534547
36.39342861085367288
Mather403728630835688110148183205
KJ,42572863083366476
Considine434828630834178117143158197212250285
RV,46482863083377382
Hamilton474628630834577135150165188225263
L,502428630833347
et508628630833557
al.51592863083324861
Combination523528630834178136176191229261283298336375
GLP-1393429630834375111131162
and411129630832967105
Insulin42312963083135076113128143180
Treatment44272963083294680112133191225263284
Fails4726296308330597489115
to485629630831956
Alter49272963083385375109130
Myocardial507229630835183120152185205243258290305
Fuel539229630833066100116
Selection55232963083296439343063083155082106121159198
vs.41473063083295670
Insulin42323063083125076113129144181
Alone44293063083385492130165
in460930630831250
Type46743063083315898134
24823306308332
Diabetes.48703063083435890129165187221247261
J5146306308322
Clin51833063083385368105
Endocrinol530430630833068106145177198214252290306
Metab393431630835490112145184
2018;103(9):3456–3465.413331630833468100131143174205238256289307319354389422456494526562598632644
37.39343261085367181
Zelniker40313263083437793132147178212234
TA,42813263083387590
Wiviott438732630836379113129167190214
SD,46173263083388495
Raz472832630834174104
I,484832630832033
et489732630833962
al.49753263083375366
Comparison505732630834583142182215237253280318358
of543032630834363
the550932630832766101
Effects39343363083335373108142168196
of414733630834363
Glucagon-Like422733630835067106139173213253293316351367398434
Peptide467733630834176117140156196232
Receptor492533630834278112147188211249272
Agonists521333630834887127167183210234263
and549233630833877118
Sodium-Glucose393434630833371111127164223245292308346379416443478
Cotransporter442834630834582104126159198224264303325349383405
24848346308340
Inhibitors49033463083205997112152168190228249277
for51953463083246284
Prevention52943463083416296129163202223239277316
of393435630833858
Major400835630836195111151173
Adverse419735630834787121156178207243
Cardiovascular445635630834680102142157197230264291325364380413435
and490735630833877118
Renal504135630834178117150167
Outcomes522435630835393116148186246283310
in555035630832160
Type393436630833260100135
24084366308332
Diabetes41313663083435890129165187220247
Mellitus.439336630835287103118132155192219232
Circulation46403663083385374105142157189211226264302
2019;139(17):2022–2031.49583663083316597127139169199232251283312331343378412445479514545579612643652
38.39343761085367389
Liu40393763083375391
X,414637630834457
Huang421937630835088121159199
J,443337630833042
Li449137630833752
J,455937630833042
Mao461737630836093132
Q,476437630835367
He484637630835086
J.494737630833043
Effects50053763083385877112145169198
of521837630834363
Liraglutide52963763083375374108147163201224240279314
Combined393438630834077135174190228263302
with42523863083496487125
Insulin43923863083135178115130145183
on459038630833674
Oxidative46803863083457792131163185201233267
Stress49633863083315273107134161
and513938630833068107
SerumMCP1526138630833166881261842522923283934396308334
and398339630833169108
NF-kB41073963083437697128165
Levels42883963083306496131146172
in447639630831351
Type45423963083325999135
24692396308333
Diabetes.47413963083445991131166188222249263
J5019396308323
Coll50573963083397692107
Physicians517939630833472102129144176191223261288
Surg54823963083316990128
Pak39344063083356797
2019;29(3):218–221.404740630833468100130143178212231264282293329360391428460494526535
39.39344161085367185
Ba403441630833669
J,411941630832537
Han417141630834577115
P,430241630833640
Yuan435741630833672104142
G,451441630834558
et458741630833557
al.46604163083324861
Randomized473641630833669107146184242257287321360
trial5112416308322435991106
assessing52344163083325985120147174189227266
the55154163083226095
safety39344263083276180115138173
and412342630833776116
efficacy4255426308340597795128162195229
of450042630834463
sitagliptin45794263083324871104144160176216238254293
in488842630832059
Chinese496342630834685100139175202238
patients521742630834579101117152191214242
with54754263083577396135
type39344363083225798135
24085436308341
diabetes41424363083446093134171194229257
mellitus4415436308364101117133149172211239
inadequately46704363083205993133169210249283305340357390
controlled507643630833775115138160199215231267308
on540043630834484
sulfonylurea5500436308332708739344463083195796128144182204239271
alone42214463083385392132167
or440444630834365
combined448544630833775134174190229264305
with48054463083577396135
metformin.495644630836399122143182204263279318331
J5303446308330
Diabetes53494463083516799139176199233261
2017(7):667–676.393445630833468100129146180200212247283316348385418450463
40.39344661085357285
Katsiki40344663083316384110124152168
N,421646630834152
Ferrannini42824663083296282102134170207220257271
E.456746630832941
Anti-inflammatory46224663083377494108129144180196213244300356387407443463496
properties51324663083345591129163183206220253279
of542546630833351
antidiabetic549146630832864849839344763083385384122157179193225
drugs:41734763083395997135161173
A4360476308342
„promised44164763083205980117174189214249287
land“47184763083164784123144
in487747630831552
the49444763083225994
COVID-19505247630834186121136181204234264
era?53304763083355688112
J5456476308325
Diabetes5496476308346619239344863083397495128154
Complications410348630833975133171187201232264285300337375401
2020;45184863083346799133145
34(12):46774863083346987118148165176
107723.48684863083336496130163197209
Epub509248630833270107146
202052524863083346799133
Aug539948630834177115
26.55294863083336679
41.39344961085366881
Yan403049630833363101
Yang,414649630833362100139152
Zixin4313496308336518297135
Cai,4464496308337708598
Jingjing45774963083223775114129144182221
Zhang.481449630833573105143182195
DPP-4502449630834379114135172
inhibitors52114963083125088103142158180217239266
may549249630835588118
improve393450630831572111133170202237
the41865063083236196
mortality429850630835997119143176191206229262
of457650630833958
coronavirus46495063083337092129167200231247268306333
disease49975063083405581116148174209
2019:522250630833569101131145
A5382506308342
meta-544050630835792115147170
-analysis.39345163083215391123139171198212239252
PLoS420251630833566103135
One.435251630834786121133
2021;16(5):e0251916.450151630833468101132140170202221254272284319355387422453483516547560
eCollection507651630833476113128144178211235250288327
2021.541851630833468101133142
42.39345261085367086
Bassendine40355263083387197124159197236251289324
MF,43755263083568995
Bridge44865263083375974113152187
SH,46885263083357992
McCaughan479552630835789130163201240278310348
GW,5158526308346105114
Gorrell528852630834684106128162177192
MD.5496526308357102114
COVID-19393453630834085121137183206237267
and421753630832967106
comorbidities:433853630832966124162184223239278293315331365392404
A4758536308338
role48125363083205773108
for49355363083165475
dipeptidyl50265363083355089125164186201240272288
peptidase532953630833772111133149187220246281
43934546308334
(DPP4)398354630832268104139171188
in418654630831856
disease42575463083425783118150176211
severity?44845463083296496130152167190223247
J4746546308328
Diabetes47895463083486496135171193227253
2020;12(9):649–658.505854630833771104138151181211228261279291326363396433471504538552
Epub393455630833372110149
2020409855630833468101135
May424955630835487118
27.43825563083346773